Mercer Global Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339K Sell
14,252
-5,324
-27% -$102K ﹤0.01% 2672
2026
Q1
$345K Buy
19,576
+4,124
+27% +$82.8K ﹤0.01% 2306
2025
Q4
$305K Buy
15,452
+996
+7% +$17.9K ﹤0.01% 2220
2025
Q3
$252K Buy
+14,456
New +$214K ﹤0.01% 2214
2023
Q4
Sell
-10,000
Closed -$69K 2005
2023
Q3
$69K Hold
10,000
﹤0.01% 1876
2023
Q2
$58K Sell
10,000
-7,842
-44% -$50.7K ﹤0.01% 1862
2023
Q1
$113K Sell
17,842
-10,000
-36% -$95.4K ﹤0.01% 1818
2022
Q4
$327K Hold
27,842
﹤0.01% 1456
2022
Q3
$330K Hold
27,842
﹤0.01% 1351
2022
Q2
$318K Hold
27,842
﹤0.01% 1397
2022
Q1
$313K Hold
27,842
﹤0.01% 1484
2021
Q4
$391K Buy
+27,842
New +$488K ﹤0.01% 1340

Other funds holding ALHC

Mercer Global Advisors's ALHC Position: Q2 2026 in Review

Mercer Global Advisors reduced its Alignment Healthcare (ALHC) stake by 27% in Q2 2026, selling an estimated $102K and leaving 14,252 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

Mercer Global Advisors first reported a position in ALHC in Q4 2021 and has held it in 12 quarters since. The position peaked at $391K in Q4 2021. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Mercer Global Advisors held 14,252 shares of Alignment Healthcare worth $339K as of Q2 2026.
  • Mercer Global Advisors sold 5,324 Alignment Healthcare shares in Q2 2026, an estimated $102K.
  • Alignment Healthcare made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2672 holding.
  • Mercer Global Advisors first reported a position in Alignment Healthcare in Q4 2021 and has held it in 12 quarters since.
  • Mercer Global Advisors's Alignment Healthcare position peaked at $391K in Q4 2021.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.